Italian pharmaceutical glassware investment completed

Italian pharmaceutical glassware investment completed

Bormioli Pharma’s recently renovated plant at San Vito al Tagliamento in north eastern Italy features a larger furnace and two new production lines, significantly increasing its manufacturing capacity. When fully operational, the €20 million investment will see capacity increase from 30 tons/day to 110 tons/day, with the possibility of adding a third production line to extend the plant’s maximum capacity to 150 tons/day.

Featuring cutting-edge technologies in different areas, the plant has been designed to ensure high operational flexibility and to operate with different formats and production technologies. In addition to high standards of energy efficiency, the plant now features a system of prevention and safety, as well as the latest emission control mechanism.

"The decision to invest in the renovation and development of our plant in San Vito responds to the company's growth plans and the need to improve our level of service, further reducing lead times and ensuring product availability even during periodic maintenance of our production site in Bergantino” explains Andrea Lodetti, CEO of Bormioli Pharma. “The construction of this plant further confirms the company's ability to improve continuously, through the integration and development of its technological skills on production processes. With the inauguration of the new plant, we have strengthened our position, further establishing the company as a partner of excellence in the global pharmaceutical industry."


Hot Topics